Skip to main navigation Skip to search Skip to main content

DEFENDER trial: dapagliflozin for critically ill patients with acute organ dysfunction - implications for clinicians

  • ERAKI Working Group of the European Renal Association

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)1267-1269
Number of pages3
JournalNephrology Dialysis Transplantation
Volume40
Issue number7
DOIs
Publication statusPublished - 1 Jul 2025

Cite this